Lexicon Announces Virtual Webcast on LX9211 for Diabetic Peripheral Neuropathic Pain
(NASDAQ:LXRX), THE WOODLANDS, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the company will host a virtual webcast: “LX9211 – Changing the Paradigm for Treatment of Neuropathic Pain.” The event will be held from 9:00 a.m. to 11:00 a.m. ET on January 28, 2025. In advance of topline […]